EP Biocomposites Share Price Today | Stock Price & EP Biocomposites Share Screener
Track the current EP Biocomposites share price and stock price live with TickJournal's free stock screener. Check EPBIO yearly price range for the annual price range and momentum. Use the EP Biocomposites stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today EP Biocomposites opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
EP Biocomposites Share Price Chart
Track the current stock price of EP Biocomposites with an interactive chart. Analyse EPBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete EP Biocomposites stock quote in one place.
EP Biocomposites Company Profile - Fundamental Screener
Screen EP Biocomposites company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EPBIO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Utilities sector and the Waste Management industry, and it trades under ISIN INE0D2I01014.
Company Details
Classification
Identifiers and Leadership
EP Biocomposites Balance Sheet Screener
Screen EPBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹19, up from ₹17 in 2025.
Latest statistics put total assets at ₹19 and shareholder funds at ₹12, with a leverage ratio of 0.24.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 19 | 17 | 15 | 12 | 9 | 1 | 1 |
| Current Assets | 16 | 14 | 13 | 9 | 9 | 1 | 1 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 1 | 1 | 2 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 12 | 11 | 10 | 8 | 2 | 0 | 0 |
| Share Capital | 2 | 2 | 2 | 2 | 1 | 0 | 0 |
| Reserves & Surplus | 10 | 9 | 8 | 7 | 1 | 0 | 0 |
EP Biocomposites Income Statement Screener - Profit & Revenue Analysis
Screen EP Biocomposites income statement and profit fundamentals. Analyze EPBIO quarterly results. EP Biocomposites reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹14 and net profit of ₹2.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 0 | 14 | 12 | 12 | 7 | 8 | 3 | 1 |
| Expenses | 0 | 11 | 10 | 10 | 6 | 7 | 3 | 1 |
Operating Costs and Margins | ||||||||
| EBITDA | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 0 |
| Operating Profit % | 0.00% | 16.00% | 15.00% | 12.00% | 13.00% | 17.00% | 16.00% | 8.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||||||
| Profit Before Tax | 0 | 2 | 1 | 2 | 1 | 1 | 1 | 0 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| EPS | 0.00 | 8.67 | 6.13 | 6.84 | 3.94 | 9.48 | 6.97 | 0.61 |
EP Biocomposites Cash Flow Screener - Liquidity Fundamentals
Screen EPBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹2, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹1 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||
| Operating Activities | 2 | -1 | -1 | -1 | -4 | 0 | 0 |
| Investing Activities | -1 | 0 | 0 | 0 | -1 | 0 | 0 |
Financing and Net Cash | |||||||
| Financing Activities | -1 | 1 | 1 | 3 | 5 | 0 | 0 |
| Net Cash Flow | 1 | 0 | -1 | 2 | 0 | 0 | 0 |
EP Biocomposites Shareholding Pattern Screener
See EP Biocomposites shareholding pattern with promoter, FII, and DII holdings. Check EP Biocomposites promoter holding and ownership changes for EPBIO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 70.08%, foreign institutions 0.00%, domestic institutions 0.00% and the public 26.83%, spread across 353 shareholders.
The shareholder count was 353 in 2026-Mar, compared with 337 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 70.08% | 70.08% | 70.08% | 70.08% | 70.05% | 70.08% | 70.08% | 70.08% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.20% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.83% | 26.62% | 26.41% | 26.05% | 26.35% | 26.50% | 23.47% | 24.69% |
| Other Holding | 3.09% | 3.30% | 3.51% | 3.87% | 3.60% | 3.42% | 4.25% | 5.23% |
| Shareholder Count | 353 | 337 | 382 | 374 | 361 | 356 | 339 | 374 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by EP Biocomposites. EP Biocomposites dividend yield can be compared with peers and other stocks in the market.
EP Biocomposites Stock Index Membership - Nifty & Sensex
See which indices include EP Biocomposites stock. Check EPBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
EP Biocomposites Market Events Screener - Corporate Actions
Get EP Biocomposites corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check EP Biocomposites stock events that may affect EPBIO share price, along with derivatives, futures and options activity and sector gainers.
6 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.
It is followed by Quarterly Result Announcement dated May 26, 2026 and Quarterly Result Announcement dated November 3, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | 1.60% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -1.01% |
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | 5.69% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -2.52% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -5.60% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -0.92% |
EP Biocomposites Competitors Screener - Peer Stocks Comparison
Screen EPBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Utilities sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| EMS | 1,874 | 27.72 | 745 | -24.11% | 91 | 29.10 |
| Antony Waste Handling Cell | 1,034 | 15.08 | 1,084 | 13.07% | 92 | 43.20 |
| Effwa Infra & Research | 836 | 28.22 | 253 | 36.84% | 29 | 51.99 |
| Eco Recycling | 778 | 32.57 | 53 | 14.04% | 23 | 22.42 |
| Namo eWaste Management | 765 | 54.82 | 195 | 29.03% | 14 | 65.49 |
| Concord Enviro Systems | 537 | -75.16 | 586 | -2.25% | 23 | 42.11 |
| VVIP Infratech | 363 | 8.57 | 350 | -6.30% | 43 | 62.50 |
| Hi-Green Carbon | 307 | 83.18 | 141 | 42.87% | 3 | 50.49 |
| Organic Recycling Systems | 306 | 11.87 | 105 | 115.75% | 25 | 67.63 |
| Race Eco Chain | 207 | 26.61 | 620 | 11.58% | 7 | 66.95 |
EP Biocomposites Company Announcements - News & Reports Screener
Screen EPBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated and .
| Date | Update | Actions |
|---|---|---|
| Intimation Of Strategic Collaboration And Consultancy Agreement Entered With Malligavad Foundation And Anand Malligavad | - | |
| Closure of Trading Window | - | |
| Shareholder Meeting / Postal Ballot-Outcome of AGM | - | |
| 2026-10-03 | Intimation For Order Award For 70KLD STP Unit | - |
| 2026-10-03 | Chairmans Speech Proposed To Be Delivered In The Upcoming Annual General Meeting | - |
| 2026-09-28 | Presentation Prepared For The Upcoming Annual General Meeting Of The Company | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Intimation Of The Seventh Annual General Meeting To Be Held On September 28 2026 | - |
| 2026-05-29 | Press Release On The Financial Results For The Half Year And Year Ended March 31 2026 | - |
| 2026-05-26 | Financial Results For The Year Ended March 31 2026 | - |
| 2026-05-26 | Board Meeting Outcome for Outcome Of The Board Meeting Along With The Financial Results For The Year Ended March 31 2026 | - |
| 2026-05-20 | Board Meeting Intimation for Board Meeting Scheduled To Approve The Financial Results For The Year Ended March 31 2026 | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-02-18 | Intimation Of Press Release - EP Biocomposites Strengthens Technology Capabilities Through Strategic Collaboration With Iisc Bengaluru | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2025-11-03 | Financial Results For The Half Year Ended September 30 2025 | - |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting- Financial Results For The Half Year Ended September 30 2025 | - |
| 2025-10-30 | Board Meeting Intimation for Consideration Of The Financial Results For The Half Year Ended September 30 2025 | - |
| 2025-10-03 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.37. Market capitalisation stands at ₹16.50 Cr. The company operates in the Utilities sector, in the Waste Management industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.